Published by Bianca Boorer on 16th September 2016
(ShareCast News) - Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, has reported a third consecutive full year loss due to the costs involved in its expansion in the US.
URL: http://www.digitallook.com/dl/news/story/24965816/...